Forman M. Quantification of Plasma DNA as a Prognostic Indicator in Canine
Lymphoid Neoplasia.
Not exact matches
The diagnosis of 6 cases were as follows; three diffuse large B cell lymphomas, two mucosa - associated
lymphoid tissue lymphomas and one of other B cell
neoplasias.
Purpose of Study: Recent studies in dogs with
lymphoid cell
neoplasia have demonstrated the safety and efficacy of Tanovea - CA1 ™ and have led to its conditional FDA approval.